The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Ipilimumab-induced hypophysitis in melanoma patients.
Typhanie Carré
No relevant relationships to disclose
Caroline Gaudy-Marqueste
Honoraria - Bristol-Myers Squibb
Frédérique Albarel
No relevant relationships to disclose
Sandrine Monestier
No relevant relationships to disclose
Stéphanie Mallet
Other Remuneration - Bristol-Myers Squibb
Thierry Brue
No relevant relationships to disclose
Marie-Aleth Richard
No relevant relationships to disclose
Jean Jacques Grob
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb